HansBiomed Corporation (KOSDAQ:042520)

HansBiomed Ratios and Metrics

Market cap in millions KRW. Fiscal year is October - September.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 4, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Market Capitalization	366,233	127,792	207,570	92,964	160,691	226,346
Market Cap Growth	244.74%	-38.43%	123.28%	-42.15%	-29.01%	9.48%
Enterprise Value	398,619	153,787	241,607	132,643	187,080	248,070
Last Close Price	28200.00	9840.00	17930.00	9610.00	16050.00	22850.00
PE Ratio	-	-	-	15.12	-	-
Forward PE	34.56	20.86	20.86	20.86	20.86	20.86
PS Ratio	4.28	1.58	2.66	1.25	2.72	2.83
PB Ratio	5.89	1.90	4.16	1.96	3.38	3.27
P/TBV Ratio	5.93	1.93	4.29	2.08	3.70	3.98
P/OCF Ratio	-	72.67	-	-	-	39.36
EV/Sales Ratio	4.66	1.90	3.10	1.78	3.17	3.10
EV/EBITDA Ratio	233.25	25.58	231.57	21.54	-	1203.72
EV/EBIT Ratio	-	245.82	-	105.60	-	-
EV/FCF Ratio	-108.68	-	-	-	-	-
Debt / Equity Ratio	0.69	0.54	0.82	1.18	1.08	0.47
Debt / EBITDA Ratio	8.12	6.06	39.43	9.08	-	159.38
Asset Turnover	0.67	0.67	0.61	0.57	0.45	0.60
Inventory Turnover	1.19	1.05	1.20	1.26	1.64	2.28
Quick Ratio	0.55	0.38	0.31	0.32	0.49	1.36
Current Ratio	1.05	0.99	0.77	0.73	0.84	2.09
Return on Equity (ROE)	-15.31%	-13.33%	-49.47%	10.36%	-37.86%	-23.70%
Return on Assets (ROA)	0.00%	0.32%	-2.04%	0.60%	-9.46%	-1.60%
Return on Capital (ROIC)	0.00%	0.40%	-2.67%	0.78%	-12.28%	-1.94%
Return on Capital Employed (ROCE)	0.00%	0.90%	-7.30%	2.20%	-28.90%	-3.30%
Earnings Yield	-2.72%	-5.65%	-11.10%	6.61%	-11.38%	-7.88%
FCF Yield	-1.00%	-0.65%	-2.73%	-8.88%	-12.16%	-0.57%
Buyback Yield / Dilution	-2.92%	-20.83%	18.41%	-31.21%	-1.48%	-0.37%
Total Shareholder Return	-2.92%	-20.83%	18.41%	-31.21%	-1.48%	-0.37%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.